Cat.#: ACPP-1328
| Despition | MRAP2 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1784 | Human GPI Protein (AC1784) | 5 µg | inquiry |
| ACPP-1380 | Human LECT2 Protein (AC1380) | 2 µg | inquiry |
| ACPP-1560 | Human RBM17 Protein (AC1560) | 2 µg | inquiry |
| ACPP-1079 | Dopamine Receptor D1 Blocking Peptide (AC1079) | 250 µg | inquiry |
| ACPP-1839 | Human Ornithine Aminotransferase Protein (AC1839) | 5 µg | inquiry |
| ACPP-1342 | ORP150 Blocking Peptide (AC1342) | 250 µg | inquiry |
| ACPP-1043 | Recombinant Human MERTK Protein (Fc Tag) (AC1043) | 50 µg | inquiry |
| ACPP-1546 | Human HNMT Protein (AC1546) | 5 µg | inquiry |
| ACPP-1179 | Recombinant Human Gastrin Releasing Peptide Protein (Fc Tag) (AC1179) | 50 µg | inquiry |
| ACPP-1334 | DRP1 Blocking Peptide (AC1334) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.